Home Investors News Press Releases

If you would like to be alerted when a press release is added to this site, please register with the Alerting Service.

Select a month	AllJanuary February March April May June July August September October November December
Select a year	All2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Search for:

08/13/2010	Cyclacel Pharmaceuticals’ 6% convertible exchangeable preferred stockholders request special meeting to elect directors
08/05/2010	Cyclacel Pharmaceuticals reports second quarter 2010 financial results
07/29/2010	Cyclacel Pharmaceuticals to announce release of second quarter 2010 financial results
07/01/2010	Cyclacel Pharmaceuticals announces FDA orphan drug designation for sapacitabine in both AML and MDS
06/28/2010	Cyclacel Pharmaceuticals added to Russell Microcap Index
06/18/2010	Cyclacel answers Celgene’s declaratory judgment complaint and counterclaims for infringement of four Cyclacel patents
06/07/2010	Cyclacel reports interim Phase 2 sapacitabine data in myelodysplastic syndromes at 2010 ASCO annual meeting
05/21/2010	Cyclacel Pharmaceuticals to report new sapacitabine Phase 2 interim results in MDS at the American Society of Clinical Oncology Annual Meeting
05/13/2010	Cyclacel Pharmaceuticals reports financial results for first quarter 2010
05/13/2010	Cyclacel to restate 2009 annual financial statements to correct net loss per share
1  2  3    >>

  Go to top      Print page